Concepedia

Author

Naoshi Odagiri

Osaka City University

Also Known As

N Odagiri, N. Odagiri, Naoshi Odagiri

31

Publications

271

Citations

9

H-Index

10

Concepts

All Affiliations

Osaka City UniversityKashiwa Municipal HospitalTokyo Metropolitan UniversityOsaka Metropolitan University
NO

About

Naoshi Odagiri is an author at Osaka City University specializing in developmental biology, cell death, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

16

2

Cell Biology

1

1

16

3

Cellular Physiology

1

1

16

4

Cell Signaling

1

1

16

5

Developmental Biology

1

1

16

Naoshi Odagiri

×

7

Publications

154

Citations

7

H-Index

YearCitations

Clinical significance of circulating soluble immune checkpoint proteins in sorafenib-treated patients with advanced hepatocellular carcinoma

Minh Phuong Dong, Masaru Enomoto, Lê Thị Thanh Thủy,

Scientific Reports

2020

61

Lenvatinib-Induced Tumor-Related Hemorrhages in Patients with Large Hepatocellular Carcinomas

Sawako Uchida‐Kobayashi, Ken Kageyama, Akira Yamamoto,

Oncology

2020

23

Early Change in the Plasma Levels of Circulating Soluble Immune Checkpoint Proteins in Patients with Unresectable Hepatocellular Carcinoma Treated by Lenvatinib or Transcatheter Arterial Chemoembolization

Naoshi Odagiri, Hoang Hai, Lê Thị Thanh Thủy,

Cancers

2020

19

Involvement of ERK1/2 activation in the gene expression of senescence-associated secretory factors in human hepatic stellate cells

Naoshi Odagiri, Tsutomu Matsubara, Moe Higuchi,

Molecular and Cellular Biochemistry

2018

16

Stress can attenuate hepatic lipid accumulation via elevation of hepatic β-muricholic acid levels in mice with nonalcoholic steatohepatitis

Sayuri Takada, Tsutomu Matsubara, Hideki Fujii,

Laboratory Investigation

2020

13

Short-term hepatocyte function and portal hypertension outcomes of sofosbuvir/velpatasvir for decompensated hepatitis C-related cirrhosis

Kohei Kotani, Masaru Enomoto, Sawako Uchida‐Kobayashi,

Journal of Gastroenterology

2023

12

A case of hepatocellular carcinoma with “pseudoprogression” followed by complete response to atezolizumab plus bevacizumab

Naoshi Odagiri, Akihiro Tamori, Kohei Kotani,

Clinical Journal of Gastroenterology

2023

10

Page 1